Hospital Universitario Puerta Del Mar

At Hospital Universitario Puerta Del Mar, clinical trials in neoplasms focus on cancers such as acute myeloid leukemia, lymphoma, breast cancer, bladder cancer, prostate cancer, and pancreatic cancer. These studies are mainly designed to test new treatment strategies, compare them with current care, and improve outcomes for patients with difficult-to-treat malignancies.

• Testing new approaches for blood cancers, including acute myeloid leukemia and B-cell lymphoma
• Evaluating treatment options in breast cancer, prostate cancer, and pancreatic adenocarcinoma
• Studying bladder cancer care in non-muscle-invasive and muscle-invasive disease

The site’s work in oncology also includes efforts to improve survival, delay progression, and refine treatment choices for patients with advanced or high-risk disease.

Research in cardiovascular diseases and nutritional and metabolic diseases includes studies in severe hypertriglyceridemia, aortic stenosis, spontaneous coronary artery dissection, cardiomyopathy, and familial hypercholesterolemia. These trials aim to improve prevention, reduce complications, and assess whether newer therapies can better control risk factors and cardiovascular events.

• Exploring treatments for severe hypertriglyceridemia and heterozygous familial hypercholesterolemia
• Assessing care for spontaneous coronary artery dissection and severe symptomatic aortic stenosis
• Studying therapies for idiopathic dilated cardiomyopathy and secondary prevention of cardiovascular events

This area reflects a strong interest in both long-term risk reduction and better management of serious heart and lipid disorders.

Trials in nervous system diseases at this site address multiple sclerosis, relapsing multiple sclerosis, primary progressive multiple sclerosis, migraine, medication overuse headache, and cervical dystonia. The main goal is to evaluate treatments that may reduce relapses, improve disability outcomes, and ease symptoms that affect daily life.

• Testing therapies for relapsing and primary progressive multiple sclerosis
• Studying options for migraine and medication overuse headache
• Evaluating symptom relief in cervical dystonia and fatigue-related neurologic conditions

The Hospital Universitario Puerta Del Mar contributes to research aimed at improving both disease control and quality of life in chronic neurologic disorders.

Studies in respiratory tract diseases and immune-related complications include idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, eosinophilic asthma, septic shock, acute pancreatitis, and kidney-related problems such as delayed graft function after kidney transplantation. These trials are focused on finding better ways to preserve organ function, reduce severe complications, and support recovery in high-risk patients.

• Evaluating treatments for pulmonary fibrosis and severe asthma
• Investigating care for septic shock and acute pancreatitis
• Studying kidney transplant outcomes, including delayed graft function and infection prevention

This research combines intensive-care, lung, and transplant medicine with the aim of improving survival and recovery in complex clinical settings.

A substantial part of the portfolio covers immune system diseases, skin and connective tissue diseases, and related inflammatory conditions such as hidradenitis suppurativa, chronic spontaneous urticaria, and atopic dermatitis. These trials are designed to assess whether new therapies can better control inflammation, reduce symptoms, and maintain long-term disease improvement.

• Testing treatment options for hidradenitis suppurativa and chronic spontaneous urticaria
• Evaluating therapies for atopic dermatitis in children and adults
• Measuring symptom reduction and durability of response in chronic inflammatory skin disease

The research reflects a strong focus on persistent immune-driven conditions where patients often need better long-term control.

Additional trials at Hospital Universitario Puerta Del Mar span eye diseases, digestive system diseases, and neonatal and pediatric care. Areas of interest include corneal disease, myopia, pancreatitis, hepatocellular carcinoma, and prematurity in neonates. The purpose of these studies is to improve treatment options, slow disease progression, and support vulnerable patient groups.

• Studying therapies for corneal ulcers and myopia progression
• Evaluating care in acute and recurrent pancreatitis
• Researching support strategies for preterm neonates and liver cancer patients

This mix of studies shows a broad clinical research profile, extending from vision and digestion to early-life medicine and liver oncology.